Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Depot tetracosactide
(D02105)
----[1] 83 💬
2Tetracosactide acetate
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 83, 145 💬
3Tetracosactide esacetato
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113 💬
4Tetracosactide hexaacetate
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113 💬
5Tetracosactide hexacetaat
(D02105)
[1] Tetracosactide[2] Cosyntropin ,
Tetracosactide acetate (D02105) 💬
[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 222 💬